Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255.
Annals of Oncology.
Times cited: 12
Combination trial of subcutaneous recombinant α2b interferon and oral cyclophosphamide in follicular low-grade non-Hodgkin's lymphoma.
Medical and Pediatric Oncology.
Times cited: 13
A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (Adriamycin), vincristine and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: Preliminary report of cancer and leukemia group B study 7851.
Times cited: 10